EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY

被引：0
|
作者：
Hornyak, L. [1 ]
Nagy, Z. [2 ]
Talos, Z. [1 ]
Agoston, I [2 ]
Endrei, D. [2 ]
Csakvari, T. [3 ]
Boncz, I [4 ]
机构：
[1] Csolnoky Ferenc Hosp, Veszprem, Hungary
[2] Univ Pecs, Pecs, Hungary
[3] Univ Pecs, Zalaegerszeg, Hungary
[4] Univ Pecs, Fac Hlth Sci, Pecs, Hungary
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1018
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP83
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [1] EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY
    Homyak, L.
    Nagy, Z.
    Talos, Z.
    Endrei, D.
    Agoston, I
    Csakvari, T.
    Boncz, I
    VALUE IN HEALTH, 2017, 20 (09) : A461 - A461
  • [2] EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY IN CASE OF ERYTHROPOIETIN PRODUCTS
    Nagy, Z.
    Hornyak, L.
    Talos, Z.
    Endrei, D.
    Agoston, I
    Csakvari, T.
    Boncz, I
    VALUE IN HEALTH, 2015, 18 (07) : A513 - A513
  • [3] EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY IN CASE OF COLONY-STIMULATING FACTOR PRODUCTS
    Hornyak, L.
    Nagy, Z.
    Talos, Z.
    Endrei, D.
    Agoston, I
    Csakvari, T.
    Boncz, I
    VALUE IN HEALTH, 2015, 18 (07) : A477 - A477
  • [4] Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary
    Hornyak, Lajos
    Nagy, Zsolt
    Ilku, Livia
    Talos, Zsuzsanna
    Endrei, Dora
    Agoston, Istvan
    Csakvari, Timea
    Danku, Nora
    Repasy, Balazs
    Boncz, Imre
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (06) : 725 - 731
  • [5] Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
    Dickson, Sean R.
    Kent, Tyler
    JAMA NETWORK OPEN, 2021, 4 (11) : E2133451
  • [6] ORIGINAL VS BIOSIMILAR DRUGS PRICE DIFFERENCES IN EU COUNTRIES
    Psenkova, M.
    Mackovicova, S.
    VALUE IN HEALTH, 2019, 22 : S680 - S680
  • [7] Price of some drugs in Hungary to rise 30% for patients
    Kovac, C
    BRITISH MEDICAL JOURNAL, 1999, 318 (7183): : 556 - 556
  • [8] Competition: An antidote to the high price of prescription drugs
    Stein, P
    Valery, E
    HEALTH AFFAIRS, 2004, 23 (04) : 151 - 158
  • [9] TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5
    Lopez, N.
    Prada, M.
    Berard, I
    Schleich, W.
    Melson, C.
    VALUE IN HEALTH, 2018, 21 : S186 - S187
  • [10] The biosimilar price is right
    Gaugh, David
    NATURE BIOTECHNOLOGY, 2013, 31 (11) : 971 - 971
12345